Caduet and Infusion related reaction - a phase IV clinical study of FDA data

Summary:

Infusion related reaction is reported as a side effect among people who take Caduet (amlodipine besylate; atorvastatin calcium), especially for people who are male, 60+ old, also take Incruse Ellipta, and have Immunodeficiency common variable.

The phase IV clinical study analyzes which people have Infusion related reaction when taking Caduet. It is created by eHealthMe based on reports of 4,989 people who have side effects when taking Caduet from the FDA, and is updated regularly.

What is Caduet?

Caduet has active ingredients of amlodipine besylate; atorvastatin calcium. It is often used in high blood pressure. eHealthMe is studying from 5,157 Caduet users. Check the latest studies of Caduet.

What is Infusion related reaction?

Infusion related reaction is found to be associated with 1,530 drugs and 1,353 conditions by eHealthMe. Check the latest studies of Infusion related reaction.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

4,989 people reported to have side effects when taking Caduet.
Among them, 12 people (0.24%) have Infusion related reaction.

Could Caduet cause Infusion related reaction?

Among these 12 people:

What is the gender of people who have Infusion related reaction when taking Caduet? *

female: 8.33 %
male: 91.67 %

What is the age of people who have Infusion related reaction when taking Caduet? *

What are other drugs people take besides Caduet? *

What are other side effects people have besides Infusion related reaction? *

Fatigue (feeling of tiredness): 9 people, 75.00%
Productive Cough: 8 people, 66.67%
Tinnitus (a ringing in the ears): 7 people, 58.33%
Pneumonia: 7 people, 58.33%
Pain: 7 people, 58.33%
Fever: 7 people, 58.33%
Lower Respiratory Tract Infection: 7 people, 58.33%
Cataract (clouding of the lens inside the eye): 5 people, 41.67%
Dental Caries: 5 people, 41.67%
Drowsiness: 4 people, 33.33%

What are the existing conditions these people have? *

Immunodeficiency Common Variable: 9 people, 75.00%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 2 people, 16.67%
Interstitial Lung Disease: 2 people, 16.67%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 8.33%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Caduet and have Infusion related reaction?

- Check whether Infusion related reaction is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Caduet:

Caduet (5,157 reports)

Infusion related reaction treatments and more:

Infusion related reaction (72,553 reports)

How severe was Infusion related reaction and when was it recovered:

Infusion related reaction in Caduet

Expand to all the drugs that have ingredients of amlodipine besylate; atorvastatin calcium:

Infusion related reaction and drugs with ingredients of amlodipine besylate; atorvastatin calcium

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Caduet:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Infusion related reaction:

Infusion related reaction (1,530 drugs)

Browse all the conditions that are associated with Infusion related reaction:

Infusion related reaction (1,353 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on amlodipine besylate; atorvastatin calcium (the active ingredients of Caduet) and Caduet (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.